Spineway Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Stephane Le Roux

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	no data
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	6yrs
Gemiddelde ambtstermijn bestuur	geen gegevens

Recente managementupdates

Recent updates

Not Many Are Piling Into Spineway SA (EPA:ALSPW) Stock Yet As It Plummets 32%

Mar 19

Market Might Still Lack Some Conviction On Spineway SA (EPA:ALSPW) Even After 162% Share Price Boost

Jan 31

Is Spineway (EPA:ALSPW) Using Debt Sensibly?

Apr 12

Spineway Société Anonyme (EPA:ALSPW) Has Debt But No Earnings; Should You Worry?

Dec 27

Is Spineway Société Anonyme (EPA:ALSPW) Using Too Much Debt?

May 14

Spineway Société Anonyme's (EPA:ALSPW) Shift From Loss To Profit

Mar 22

Spineway Société Anonyme (EPA:ALSPW) Has Debt But No Earnings; Should You Worry?

Jan 28

CEO

Stephane Le Roux

no data

Tenure

€121,331

Compensatie

Mr. Stephane Le Roux serves as the Chairman, CEO and President of Spineway Société Anonyme.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Stephane Le Roux	Chairman	no data	€121.33k	geen gegevens
Philippe Laurito	Director & CTO of Spineway Inc.	6yrs	€121.33k	geen gegevens
David Siegrist	Financial Director	no data	geen gegevens	geen gegevens
Agnès Mignani	Human Resources Manager	no data	geen gegevens	geen gegevens
Sandrine Carle	Deputy Chief Executive Officer	less than a year	geen gegevens	geen gegevens
Guillaume Bertet	Controller	no data	geen gegevens	geen gegevens
Mickaël Battisti	Controller	no data	geen gegevens	geen gegevens
Marie-Christelle Desmolles	Controller	no data	geen gegevens	geen gegevens
Jon Luedke	CEO of Spineway Inc.	6yrs	geen gegevens	geen gegevens

6.0yrs

Gemiddelde duur

Ervaren management: Het managementteam van ALSPW is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6 jaar).

Spineway Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Spineway SA, Annual General Meeting, Mar 25, 2024

Spineway SA, Annual General Meeting, Mar 25, 2024

Spineway Sa Announces the Appointment of Sandrine Carle as Deputy Chief Executive Officer

Less than half of directors are independent

Spineway SA, Annual General Meeting, May 18, 2022

Less than half of directors are independent

Recent updates

New minor risk - Financial data availability

Spineway SA to Report First Half, 2024 Results on Sep 24, 2024

Not Many Are Piling Into Spineway SA (EPA:ALSPW) Stock Yet As It Plummets 32%

Spineway SA, Annual General Meeting, Mar 25, 2024

Full year 2023 earnings released

Spineway SA, Annual General Meeting, Mar 25, 2024

Market Might Still Lack Some Conviction On Spineway SA (EPA:ALSPW) Even After 162% Share Price Boost

Spineway SA to Report Q4, 2023 Results on Feb 07, 2024

Spineway Sa Announces the Appointment of Sandrine Carle as Deputy Chief Executive Officer

Spineway Group Obtains 510(K) Clearance from the US Food and Drug Administration for its VEOS Spinal Fixation System

First half 2023 earnings released

New minor risk - Financial data availability

New major risk - Shareholder dilution

Forecast to breakeven in 2023

Full year 2022 earnings released

Spineway SA to Report First Half, 2023 Results on Sep 19, 2023

Spineway SA to Report Fiscal Year 2022 Results on Feb 09, 2023

Price target decreased to €290

Less than half of directors are independent

First half 2022 earnings released

Price target increased to €0.01

Spineway SA (ENXTPA:ALSPW) agreed to acquire Spine Innovations SAS from LBO France.

Spineway SA, Annual General Meeting, May 18, 2022

Less than half of directors are independent

Is Spineway (EPA:ALSPW) Using Debt Sensibly?

Full year 2021 earnings: EPS and revenues miss analyst expectations

Spineway Société Anonyme, Annual General Meeting, Mar 23, 2022

Spineway Société Anonyme (EPA:ALSPW) Has Debt But No Earnings; Should You Worry?

Spineway Société Anonyme (ENXTPA:ALSPW) signed a memorandum of understanding to acquire Distimp.

Is Spineway Société Anonyme (EPA:ALSPW) Using Too Much Debt?

Spineway Société Anonyme's (EPA:ALSPW) Shift From Loss To Profit

Spineway in Negotiations to Acquire European Spinal Surgery Start-Up

Spineway Société Anonyme Announces Signature of A Partnership with Tsunami Medical

Spineway Société Anonyme, Annual General Meeting, Mar 08, 2021

Full year 2020 earnings released: €0.005 loss per share (vs €0.064 loss in FY 2019)

Earnings beat expectations, revenue disappoints

Spineway Société Anonyme (EPA:ALSPW) Has Debt But No Earnings; Should You Worry?

Price target raised to €0.01

Spineway Société Anonyme to Report First Half, 2021 Results on Sep 03, 2021

First half earnings released

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur